Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

158
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
158
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

250
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
250
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

196
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
196
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Data Validation01:15

Data Validation

520
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
520
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-level process validation approach for medical devices.

Journal of medical engineering & technology·2019
Same journal

News and Product Update.

Journal of medical engineering & technology·2026
Same journal

PMMA based ultra miniaturized implantable antenna for biotelemetry applications.

Journal of medical engineering & technology·2026
Same journal

Comparative machine learning for accurate EEG-based epileptic seizure state classification using sub-band analysis.

Journal of medical engineering & technology·2026
Same journal

Genetic algorithm-optimized machine learning approaches for EEG-based silent speech decoding.

Journal of medical engineering & technology·2026
Same journal

Power transition signatures of vibroarthrographic spectrograms for diagnosing knee joint pathologies.

Journal of medical engineering & technology·2026
Same journal

News and product update.

Journal of medical engineering & technology·2026
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K

OQ & PQ protocols development for medical device two-level process validation.

Yeong-Lin Chen1

  • 1Validation Department, SHL Group, Taoyuan, Taiwan.

Journal of Medical Engineering & Technology
|November 29, 2019
PubMed
Summary
This summary is machine-generated.

This study offers a structured approach to process validation (IQ/OQ/PQ) for the medical device industry. It details typical protocols and test plans for equipment and systems, addressing regulatory challenges.

Keywords:
Equipment Validation IQ/OQ/PQMedical device process validationProcess Validation PQdetailed test plantwo-level process validation

More Related Videos

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

538
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.5K

Related Experiment Videos

Last Updated: Jan 3, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

538
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.5K

Area of Science:

  • Medical Device Manufacturing
  • Regulatory Compliance
  • Quality Assurance

Background:

  • The medical device industry's diverse technologies complicate standardized process validation (IQ/OQ/PQ).
  • Existing regulatory and guidance documents lack specific definitions for IQ/OQ/PQ implementation.
  • This ambiguity poses challenges for ensuring consistent product quality and safety.

Purpose of the Study:

  • To propose a structured, two-level process validation approach (component and device assembly).
  • To define typical content and structure for IQ/OQ/PQ protocols.
  • To outline a detailed test plan for operational qualification (OQ) for common and test equipment.

Main Methods:

  • Development of a two-level process validation strategy.
  • Proposal of a standard section and subsection structure for IQ/OQ/PQ protocols.
  • Creation of a detailed OQ test plan framework.

Main Results:

  • A defined structure for IQ/OQ/PQ protocols, including a critical Test Plan section.
  • Specific guidance on validation approaches for component production and device assembly levels.
  • A detailed OQ test plan applicable to both general and specialized test equipment.

Conclusions:

  • The proposed framework enhances clarity and consistency in medical device process validation.
  • Standardized protocols and test plans facilitate regulatory compliance and quality management.
  • This approach addresses the need for specific guidance in the complex medical device sector.